Dossier
rare childhood brain disorder
Coverage of rare childhood brain disorder in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about another FDA reversal, pharma’s M&A spree and much more
The FDA will reconsider approving a gene therapy for a rare childhood brain disorder it previously rejected, following recent leadership changes. The U.S. also launched a trade investigation into Germany's plan to reduce pharmaceutical spending, which faced industry opposition and was revised.